Abstract:Neural stem/progenitor cell (NSPC) based therapy represents an attractive treatment for Alzheimer's disease (AD), the most common neurodegenerative disorder with no effective treatment to date. This can be achieved by stimulating endogenous NSPCs and/or administrating exogenously produced NSPCs. Successful repair requires the migration of NSPCs to the loci where neuronal loss occurs, differentiation and integration into neural networks. However, the progressive loss of neurons in the brain of AD patients suggests that the repair by endogenous NSPCs in the setting of AD may be defective. The production and deposition of amyloid-β1-42 (Aβ1-42) peptides is thought to be a central event in the pathogenesis of AD. Here we report that Aβ1-42 peptides inhibit the migration of in vitro cultured NSPCs by disturbing the ERK-MAPK signal pathway. We found that the migratory capacity of NSPCs was compromised upon treatment with oligomeric Aβ1-42; the inhibitory effect occurred in a dose-dependent manner. Our previous studies have shown that Aβ1-42 triggers the expression of GRK2 by unknown mechanism. Herein we found that the Aβ1-42 evoked upregulation of GRK2 expression was attenuated upon treatment with the ERK inhibitor SCH772984 at 2.5 μM, but not with inhibitors for p38 or JNK. We detected a dose-dependent increase in levels of phosphorylated ERK1/2 after incubation of cells with oligomeric Aβ1-42 peptides for 3 days. We observed that an increase in the phosphorylation of p38 and JNK coincided with reduced phosphorylation of ERK1/2 upon treatment with Aβ1-42 for 6 and/or 9 days. We hypothesize that the divergence of the activation of the MAPK family of pathways may contribute to the inhibition of NSPCs migration after the long-term incubation with Aβ1-42. Pretreatment with 1  μM MEK inhibitor U0126 reversed the effects of Aβ1-42 on GRK2 expression of and NSPC migration. Together, our results suggest that Aβ1-42 oligomers compromise the migratory capacity of NSPCs through the MEK-ERK pathway.

Beta-Amyloid(42) Induces Desensitization of Cxc Chemokine Receptor-4 Via Formyl Peptide Receptor in Neural Stem/Progenitor Cells

β-Amyloid<sub>42</sub> Induces Desensitization of CXC Chemokine Receptor-4 <i>via</i> Formyl Peptide Receptor in Neural Stem/Progenitor Cells

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Amyloid-β1-42 Dynamically Regulates the Migration of Neural Stem/progenitor Cells Via MAPK-ERK Pathway.

[Effects of Neural Stem Cells Transplanted into an Animal Model of Alzheimer Disease on Aβ Plaques].

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Effects of the Monomeric, Oligomeric, and Fibrillar A Beta(42) Peptides on the Proliferation and Differentiation of Adult Neural Stem Cells from Subventricular Zone

Amyloid-|[beta]|1|[ndash]|42 oligomer accelerates senescence in adult hippocampal neural stem|[sol]|progenitor cells via formylpeptide receptor 2

[Effects of Transplanted Neural Stem Cells on Synaptogenesis in APP/PS1 Mice].

Effects Of Neural Stem Cells On Synaptic Proteins And Memory In A Mouse Model Of Alzheimer'S Disease

Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an App/Ps1 Double Transgenic Model of Alzheimer'S Disease

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity.

Amyloid- β 1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2

A Beta Inhibits Mesenchymal Stem Cell-Pericyte Transition Through MAPK Pathway

RhoC Involved in the Migration of Neural Stem/Progenitor Cells

Effect of Regulation of Chemerin/Chemokine-like Receptor 1/Stimulator of Interferon Genes Pathway on Astrocyte Recruitment to Aβ Plaques

Mitogen-activated Protein Kinase Signaling Pathways Are Involved in Regulating Α7 Nicotinic Acetylcholine Receptor-Mediated Amyloid-Β Uptake in SH-SY5Y Cells

Beta-Amyloid Redirects Norepinephrine Signaling To Activate The Pathogenic Gsk3 Beta/Tau Cascade

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells

Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide.